BIOMAT Database Logo BIOMAT Database Logo

Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. 1996

Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Department of Internal Medicine School of Medicine, Tokai University, Isehara City, Japan.

Patients undergoing continuous ambulatory peritoneal dialysis (CAPD) who developed sclerosing encapsulating peritonitis (SEP) were retrospectively studied in 130 centers in Japan. Among 6,923 patients undergoing CAPD between 1980 and 1994 only 62 (0.9%) given CAPD developed SEP. There were 38 men and 24 women, ranging in age from 20 to 87 years (average age, 48.3 years). These 62 patients developed SEP 10 to 138 months (average, 65.4 months) after starting CAPD. The average frequency of peritonitis before developing SEP was 3.3 times. Five of the 62 patients with SEP had no history of peritonitis, and 27 (43.5%) of them died of various causes in the study period. The major causes of death were almost invariably related to problems concerning bowel obstruction or complications of surgery, such as malnutrition or septicemia. It was concluded that SEP is one of the most serious complications of CAPD, and constant surveillance is necessary to detect SEP in patients during CAPD.

UI MeSH Term Description Entries
D007415 Intestinal Obstruction Any impairment, arrest, or reversal of the normal flow of INTESTINAL CONTENTS toward the ANAL CANAL. Intestinal Obstructions,Obstruction, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Sclerosing encapsulating peritonitis in chronic ambulatory peritoneal dialysis.
January 1990, Clinical radiology,
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Sclerosing encapsulating peritonitis associated with continuous ambulatory peritoneal dialysis: surgical management.
March 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
February 1988, British journal of clinical practice. Supplement,
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
[Sclerosing peritonitis following continuous ambulatory peritoneal dialysis].
November 1986, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent?
January 1999, Journal of nephrology,
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea.
October 2003, Nephrology (Carlton, Vic.),
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Sclerosing encapsulating peritonitis in pediatric peritoneal dialysis patients.
April 2000, Pediatric nephrology (Berlin, Germany),
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis.
July 1983, Lancet (London, England),
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
Encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis in Japan.
January 2002, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
Y Nomoto, and Y Kawaguchi, and H Kubo, and H Hirano, and S Sakai, and K Kurokawa
[Encapsulating peritonitis during continuous ambulatory peritoneal dialysis. A physiopathologic hypothesis].
September 1986, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!